STAAR Surgical Files 8-K
Ticker: STAA · Form: 8-K · Filed: Mar 18, 2024 · CIK: 718937
| Field | Detail |
|---|---|
| Company | Staar Surgical Co (STAA) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
STAAR Surgical dropped an 8-K on 3/18 - check it for Reg FD, other events, and financials.
AI Summary
STAAR Surgical Company filed an 8-K on March 18, 2024, reporting on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company's principal executive offices are located at 25651 Atlantic Ocean Drive, Lake Forest, California.
Why It Matters
This 8-K filing provides updates on company events and financial information, which are crucial for investors to understand the latest developments at STAAR Surgical.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating any immediate material adverse changes.
Key Players & Entities
- STAAR Surgical Company (company) — Registrant
- March 18, 2024 (date) — Date of report
- 25651 Atlantic Ocean Drive, Lake Forest, California 92630 (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for STAAR Surgical Company?
The primary purpose is to report on Regulation FD disclosures, other events, and financial statements and exhibits as of March 18, 2024.
When was the report filed?
The report was filed on March 18, 2024.
Where are STAAR Surgical Company's principal executive offices located?
The principal executive offices are located at 25651 Atlantic Ocean Drive, Lake Forest, California 92630.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number is 95-3797439.
Filing Stats: 592 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-03-18 07:04:46
Filing Documents
- staa-20240318.htm (8-K) — 45KB
- staa-ex99_1.htm (EX-99.1) — 25KB
- staa-ex99_2.htm (EX-99.2) — 16KB
- img178254853_0.jpg (GRAPHIC) — 57KB
- img178254853_1.jpg (GRAPHIC) — 26KB
- staa-ex99_1s1.jpg (GRAPHIC) — 169KB
- staa-ex99_1s2.jpg (GRAPHIC) — 530KB
- staa-ex99_1s3.jpg (GRAPHIC) — 632KB
- staa-ex99_1s4.jpg (GRAPHIC) — 260KB
- staa-ex99_1s5.jpg (GRAPHIC) — 390KB
- staa-ex99_1s6.jpg (GRAPHIC) — 407KB
- staa-ex99_1s7.jpg (GRAPHIC) — 279KB
- staa-ex99_1s8.jpg (GRAPHIC) — 560KB
- staa-ex99_1s9.jpg (GRAPHIC) — 469KB
- staa-ex99_1s10.jpg (GRAPHIC) — 329KB
- staa-ex99_1s11.jpg (GRAPHIC) — 133KB
- staa-ex99_1s12.jpg (GRAPHIC) — 413KB
- staa-ex99_1s13.jpg (GRAPHIC) — 304KB
- staa-ex99_1s14.jpg (GRAPHIC) — 273KB
- staa-ex99_1s15.jpg (GRAPHIC) — 234KB
- staa-ex99_1s16.jpg (GRAPHIC) — 362KB
- staa-ex99_1s17.jpg (GRAPHIC) — 258KB
- staa-ex99_1s18.jpg (GRAPHIC) — 328KB
- staa-ex99_1s19.jpg (GRAPHIC) — 419KB
- staa-ex99_1s20.jpg (GRAPHIC) — 106KB
- staa-ex99_1s21.jpg (GRAPHIC) — 329KB
- staa-ex99_1s22.jpg (GRAPHIC) — 349KB
- staa-ex99_1s23.jpg (GRAPHIC) — 199KB
- staa-ex99_1s24.jpg (GRAPHIC) — 287KB
- staa-ex99_1s25.jpg (GRAPHIC) — 344KB
- staa-ex99_1s26.jpg (GRAPHIC) — 684KB
- 0000950170-24-032512.txt ( ) — 12788KB
- staa-20240318.xsd (EX-101.SCH) — 29KB
- staa-20240318_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Representatives of STAAR Surgical Company (the "Company") will give presentations to investors commencing on March 18, 2024. A copy of the slide presentation they will share is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by this reference.
01 Other Events
Item 8.01 Other Events. On March 18, 2024, the Company issued a press release reporting that more than three million of the Company's Implantable Collamer Lenses ("ICLs") have been sold globally, a copy of which is furnished as Exhibit 99.2 to this Current Report and is incorporated herein by this reference. The information furnished herewith pursuant to Items 7.01 and 8.01 of this Current Report, including Exhibits 99.1 and 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Items 7.01 and 8.01 of this Current Report, and Exhibits 99.1 and 99.2, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing .
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits Exhibit No. Description 99.1 Slide presentation of the Company dated March 18, 2024 99.2 Press release of the Company dated March 18, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STAAR Surgical Company March 18, 2024 By: /s/ Tom Frinzi Thomas Frinzi President and Chief Executive Officer